Birinyi Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.16M Buy
+17,029
New +$3.97M 1.13% 18
2024
Q2
Sell
-1,552
Closed -$246K 58
2024
Q1
$246K Sell
1,552
-255
-14% -$40.6K 0.08% 51
2023
Q4
$283K Buy
1,807
+4
+0.2% +$613 0.1% 52
2023
Q3
$281K Buy
1,803
+101
+6% +$16.7K 0.11% 50
2023
Q2
$282K Sell
1,702
-2,498
-59% -$403K 0.1% 53
2023
Q1
$651K Hold
4,200
0.27% 44
2022
Q4
$742K Sell
4,200
-4,000
-49% -$691K 0.36% 37
2022
Q3
$1.34M Buy
8,200
+5,500
+204% +$931K 0.63% 27
2022
Q2
$479K Hold
2,700
0.22% 42
2022
Q1
$479K Hold
2,700
0.17% 43
2021
Q4
$462K Sell
2,700
-250
-8% -$40.9K 0.14% 50
2021
Q3
$476K Hold
2,950
0.16% 51
2021
Q2
$486K Hold
2,950
0.17% 53
2021
Q1
$485K Hold
2,950
0.18% 51
2020
Q4
$464K Hold
2,950
0.17% 51
2020
Q3
$439K Hold
2,950
0.19% 52
2020
Q2
$415K Sell
2,950
-4,750
-62% -$692K 0.21% 51
2020
Q1
$1.01M Sell
7,700
-1,000
-11% -$142K 0.55% 30
2019
Q4
$1.27M Hold
8,700
0.53% 34
2019
Q3
$1.13M Hold
8,700
0.49% 38
2019
Q2
$1.21M Sell
8,700
-750
-8% -$104K 0.51% 37
2019
Q1
$1.32M Sell
9,450
-3,000
-24% -$402K 0.57% 37
2018
Q4
$1.61M Buy
12,450
+2,750
+28% +$384K 0.8% 26
2018
Q3
$1.34M Buy
9,700
+500
+5% +$66.4K 0.48% 33
2018
Q2
$1.12M Sell
9,200
-500
-5% -$62.4K 0.44% 37
2018
Q1
$1.24M Sell
9,700
-750
-7% -$101K 0.51% 40
2017
Q4
$1.46M Hold
10,450
0.65% 34
2017
Q3
$1.36M Sell
10,450
-750
-7% -$99.4K 0.65% 35
2017
Q2
$1.48M Buy
11,200
+1,500
+15% +$191K 0.7% 34
2017
Q1
$1.21M Sell
9,700
-1,500
-13% -$179K 0.6% 41
2016
Q4
$1.29M Sell
11,200
-600
-5% -$69.3K 0.73% 32
2016
Q3
$1.39M Buy
11,800
+200
+2% +$24.3K 0.75% 36
2016
Q2
$1.41M Buy
11,600
+400
+4% +$45.5K 0.61% 38
2016
Q1
$1.21M Sell
11,200
-3,500
-24% -$362K 0.54% 41
2015
Q4
$1.51M Sell
14,700
-2,550
-15% -$256K 0.98% 23
2015
Q3
$1.61M Buy
17,250
+5,050
+41% +$489K 0.7% 37
2015
Q2
$1.19M Sell
12,200
-214
-2% -$21.4K 0.81% 27
2015
Q1
$1.25M Buy
12,414
+214
+2% +$21.8K 0.83% 23
2014
Q4
$1.28M Sell
12,200
-500
-4% -$52.7K 0.57% 36
2014
Q3
$1.35M Hold
12,700
0.62% 33
2014
Q2
$1.33M Hold
12,700
0.61% 34
2014
Q1
$1.25M Buy
12,700
+600
+5% +$55.6K 0.63% 33
2013
Q4
$1.11M Sell
12,100
-750
-6% -$69.1K 0.59% 31
2013
Q3
$1.11M Buy
12,850
+4,000
+45% +$359K 0.63% 30
2013
Q2
$760K Buy
+8,850
New +$751K 0.46% 34

Other funds holding JNJ

Birinyi Associates's JNJ Position: Q1 2026 in Review

Birinyi Associates opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 17,029 shares worth $4.16M. The stake represents 1.13% of the portfolio and ranks #18 among its holdings. This is a return to the name: Birinyi Associates previously reported a position in JNJ as recently as Q1 2024.

Birinyi Associates first reported a position in JNJ in Q2 2013 and has held it in 45 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Birinyi Associates held 17,029 shares of Johnson & Johnson worth $4.16M as of Q1 2026.
  • Johnson & Johnson was a new Birinyi Associates position in Q1 2026.
  • Johnson & Johnson made up 1.13% of Birinyi Associates's portfolio in Q1 2026, its #18 holding.
  • Birinyi Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 45 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Birinyi Associates's 13F filing for Q1 2026, filed 4 May 2026.